EUROFINS DISCOVERY SERVICES NORTH AMERICA, LLC

Eurofins PanLabs, Inc. specializes in preclinical research and analytical testing services across the life sciences, with deep expertise in receptor profiling, in vitro screening, and dose-response analysis for pharmaceutical and environmental safety evaluation. The company delivers high-throughput biological assays to identify and characterize molecular targets, supports lead compound development through synthetic chemistry services, and conducts toxicity and safety assessments using advanced cell-based and biochemical platforms. Their technical capabilities span pharmacological target screening, assay validation, and data-driven predictive modeling for chemical safety, with a focus on non-animal testing methodologies aligned with regulatory science standards. A key differentiator is their ability to integrate complex biological data from diverse target panels to inform risk assessment and compound prioritization for federal research programs. The contractor maintains a strong, sustained relationship with the Department of Health and Human Services, delivering critical research support for drug safety and target identification initiatives, particularly through the National Institutes of Health. They also provide specialized testing services to the Environmental Protection Agency, primarily supporting the Office of Chemical Safety and Pollution Prevention with in vitro assays to evaluate environmental chemical hazards. A smaller but consistent presence with the Department of Veterans Affairs reflects their role in providing in vitro drug safety and toxicity screening for therapeutic development. Eurofins PanLabs operates primarily under NAICS 541714 and 541715, focusing on biotechnology research and physical/life sciences R&D, with additional work in testing laboratories (541380). This positions them as a niche provider of regulatory-compliant, mechanism-based biological testing for government-funded drug discovery and environmental health programs, serving as a trusted extension of federal scientific teams requiring validated, reproducible in vitro data. The company is structured as a 2L entity headquartered in Saint Charles, Missouri, with no federal certifications on record. Their geographic footprint is centered in the Midwest, supporting federal clients nationwide through specialized laboratory services and scientific collaboration.